Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Dyslipidemia

Free Subscription Articles published in Am J Cardiol Retrieve available abstracts of 34 articles: HTML format Text format

Single Articles

October 2017
1. VASHISHTHA D, McClelland RL, Ix JH, Rifkin DE, et al
   Relation Between Calcified Atherosclerosis in the Renal Arteries and Kidney Function (from the Multi-Ethnic Study of Atherosclerosis).
   Am J Cardiol. 2017;120:1434-1439.
   PubMed     Text format     Abstract available
   
   
   September 2017
2. EL SHAHAWY M, Cannon CP, Blom DJ, McKenney JM, et al
   Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II).
   Am J Cardiol. 2017;120:931-939.
   PubMed     Text format     Abstract available
   
   
   August 2017
3. TADA H, Kawashiri MA, Okada H, Nakahashi T, et al
   Assessments of Carotid Artery Plaque Burden in Patients With Familial Hypercholesterolemia.
   Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31382.
   PubMed     Text format     Abstract available
   
   
   
4. SUH Y, Lee CJ, Cho DK, Cho YH, et al
   Impact of National Health Checkup Service on Hard Atherosclerotic Cardiovascular Disease Events and All-Cause Mortality in the General Population.
   Am J Cardiol. 2017 Aug 7. pii: S0002-9149(17)31299.
   PubMed     Text format     Abstract available
   
   
   July 2017
5. SATTAR N, Toth PP, Blom DJ, Koren MJ, et al
   Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus.
   Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31220.
   PubMed     Text format     Abstract available
   
   
   
6. ALI M, Li Y, O'Neal WT, Soliman EZ, et al
   Tobacco Exposure as Determined by Serum Cotinine and Subclinical Myocardial Injury in Individuals Free from Cardiovascular Disease.
   Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31112.
   PubMed     Text format     Abstract available
   
   
   June 2017
7. GILL C, Vatcheva KP, Pan JJ, Smulevitz B, et al
   Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.
   Am J Cardiol. 2017;119:1717-1722.
   PubMed     Text format     Abstract available
   
   
   April 2017
8. YEOH J, Yudi MB, Andrianopoulos N, Yan BP, et al
   Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry).
   Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30629.
   PubMed     Text format     Abstract available
   
   
   
9. BALLANTYNE CM, Shah S, Sapre A, Ashraf TB, et al
   A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
   Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30626.
   PubMed     Text format     Abstract available
   
   
   February 2017
10. KOSMIDOU I, Redfors B, Dordi R, Dizon JM, et al
    Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial).
    Am J Cardiol. 2017 Feb 16. pii: S0002-9149(17)30118.
    PubMed     Text format     Abstract available
    
    
    
11. MOSCA L, Ballantyne CM, Bays HE, Guyton JR, et al
    Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials).
    Am J Cardiol. 2017;119:397-403.
    PubMed     Text format     Abstract available
    
    
    January 2017
12. ZAFRIR B, Jaffe R, Rubinshtein R, Karkabi B, et al
    Impact of Diabetes Mellitus on Long-Term Mortality in Patients Presenting for Coronary Angiography.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30049.
    PubMed     Text format     Abstract available
    
    
    
13. ALHALABI L, Singleton MJ, Oseni AO, Shah AJ, et al
    Relation of Higher Resting Heart Rate to Risk of Cardiovascular Versus Noncardiovascular Death.
    Am J Cardiol. 2017 Jan 5. pii: S0002-9149(16)32001.
    PubMed     Text format     Abstract available
    
    
    
14. GAUDET D, Watts GF, Robinson JG, Minini P, et al
    Effect of Alirocumab on Lipoprotein(a) Over >/=1.5 Years (from the Phase 3 ODYSSEY Program).
    Am J Cardiol. 2017;119:40-46.
    PubMed     Text format     Abstract available
    
    
    December 2016
15. PAGAN E, Chatenoud L, Rodriguez T, Bosetti C, et al
    Comparison of Trends in Mortality from Coronary Heart and Cerebrovascular Diseases in North and South America: 1980 to 2013.
    Am J Cardiol. 2016 Dec 18. pii: S0002-9149(16)31940.
    PubMed     Text format     Abstract available
    
    
    
16. JONES PH, Bays HE, Chaudhari U, Pordy R, et al
    Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials.
    Am J Cardiol. 2016;118:1805-1811.
    PubMed     Text format     Abstract available
    
    
    
17. PEREZ-CALAHORRA S, Sanchez-Hernandez RM, Plana N, Marco-Benedi V, et al
    Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.
    Am J Cardiol. 2016 Dec 2. pii: S0002-9149(16)31894.
    PubMed     Text format     Abstract available
    
    
    November 2016
18. NICHOLS GA, Reynolds K, Olufade T, Kimes TM, et al
    Effect of Combination Cholesterol-Lowering Therapy and Triglyceride-Lowering Therapy on Medical Costs in Patients With Type 2 Diabetes Mellitus.
    Am J Cardiol. 2016 Nov 4. pii: S0002-9149(16)31740.
    PubMed     Text format     Abstract available
    
    
    
19. BALLANTYNE CM, Shah S, Kher U, Hunter JA, et al
    Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
    Am J Cardiol. 2016 Nov 1. pii: S0002-9149(16)31743.
    PubMed     Text format     Abstract available
    
    
    September 2016
20. BLAHA MJ
    Personalizing Treatment: Between Primary and Secondary Prevention.
    Am J Cardiol. 2016;118.
    PubMed     Text format     Abstract available
    
    
    
21. TOTH PP
    Novel Therapies for Low-Density Lipoprotein Cholesterol Reduction.
    Am J Cardiol. 2016;118.
    PubMed     Text format     Abstract available
    
    
    
22. MIEDEMA MD, Virani SS
    Harder-to-Treat Patients: Recognizing Them and Adapting Treatment Strategies.
    Am J Cardiol. 2016;118.
    PubMed     Text format     Abstract available
    
    
    
23. TOTH PP, Catapano AL, Farnier M, Foody J, et al
    Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic Hypercholesterolemia.
    Am J Cardiol. 2016 Sep 13. pii: S0002-9149(16)31478.
    PubMed     Text format     Abstract available
    
    
    
24. KONISHI H, Miyauchi K, Shitara J, Endo H, et al
    Impact of Lipoprotein(a) on Long-term Outcomes in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.
    Am J Cardiol. 2016 Sep 13. pii: S0002-9149(16)31474.
    PubMed     Text format     Abstract available
    
    
    August 2016
25. ARMSTRONG EJ, Krueger JG
    Lipoprotein Metabolism and Inflammation in Patients With Psoriasis.
    Am J Cardiol. 2016;118:603-9.
    PubMed     Text format     Abstract available
    
    
    
26. MACIEJEWSKI ML, Mi X, Curtis LH, Ng J, et al
    Frequency of Disparities in Laboratory Testing After Statin Initiation in Subjects >/=65 Years.
    Am J Cardiol. 2016;118:376-82.
    PubMed     Text format     Abstract available
    
    
    July 2016
27. FURUHASHI M, Omori A, Matsumoto M, Kataoka Y, et al
    Independent Link Between Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and FABP4 in a General Population Without Medication.
    Am J Cardiol. 2016;118:198-203.
    PubMed     Text format     Abstract available
    
    
    
28. TERAMOTO T, Kobayashi M, Uno K, Takagi Y, et al
    Efficacy and Safety of Alirocumab in Japanese Subjects (Phase 1 and 2 Studies).
    Am J Cardiol. 2016;118:56-63.
    PubMed     Text format     Abstract available
    
    
    May 2016
29. MARTINEZ M, Brodlie S, Griesemer A, Kato T, et al
    Effects of Liver Transplantation on Lipids and Cardiovascular Disease in Children With Homozygous Familial Hypercholesterolemia.
    Am J Cardiol. 2016 May 28. pii: S0002-9149(16)30945.
    PubMed     Text format     Abstract available
    
    
    
30. GOYAL A, Gupta T, Aronow WS, Panza JA, et al
    Making the Case for Universal Treatment of Hypercholesterolemia.
    Am J Cardiol. 2016 May 5. pii: S0002-9149(16)30549.
    PubMed     Text format    
    
    
    
31. HECHT EM, Arheart KL, Lee DJ, Hennekens CH, et al
    Interrelation of Cadmium, Smoking, and Cardiovascular Disease (from the National Health and Nutrition Examination Survey).
    Am J Cardiol. 2016 May 4. pii: S0002-9149(16)30560.
    PubMed     Text format     Abstract available
    
    
    April 2016
32. BUDOFF M
    Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway of Cardiovascular Disease.
    Am J Cardiol. 2016 Apr 20. pii: S0002-9149(16)30484.
    PubMed     Text format     Abstract available
    
    
    
33. BALLANTYNE CM, McKenney JM, MacDougall DE, Margulies JR, et al
    Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy.
    Am J Cardiol. 2016 Apr 6. pii: S0002-9149(16)30430.
    PubMed     Text format     Abstract available
    
    
    March 2016
34. LEE SH, Jeong MH, Han KR, Sim DS, et al
    Comparison of Transradial and Transfemoral Approaches for Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome and Anemia.
    Am J Cardiol. 2016 Mar 2. pii: S0002-9149(16)30290.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: